MedTrace Logo

OCT Angio in Cerebral Small Vessel Disease

NCT05052788 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2021-09-29

No results posted yet for this study

Summary

The aim of the study is to: - detect changes in retinal structure and microvasculature in patients with cerebral small vessel disease using optical coherence tomography angiography , correlate these changes with brain imaging markers and determine if ( OCTA ) can be used as a screening tool for cerebral small vessel disease.

Conditions

  • Cerebral Small Vessel Disease and OCT Angio

Interventions

DEVICE

Optical coherence tomography angiography

OCT-A detects the motion of blood using intrinsic signals to capture the location of blood vessels. Despite its insensitivity to leakage and the relatively small field of view, the development of OCT-A has the potential to improve our knowledge of the physiology and pathophysiology of the eye. MRI as a stroke protocol, including T1 and T2 weighted images, diffusion weighted images (DWI), fluid attenuated inversion recovery (FLAIR), magnetic resonance angiography (MRA), and gradient recalled echo (GRE) T2\* weighted images, using a machine 1.5 tesla General Electric machine .

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-10-01
Primary Completion
2021-12-01
Completion
2022-01-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05052788 on ClinicalTrials.gov